Literature DB >> 29678041

The Reliability of Using Tablet Technology for Screening the Health of Older Adults.

Lex van Velsen1, Sanne Frazer1, Aurèle N'dja2, Nadir Ammour2, Susanna Del Signore3, Gianluca Zia4, Hermie Hermens1.   

Abstract

In this study, we assessed the reliability of using a tablet application for collecting health data among older adults, in comparison to using paper surveys for this goal. Test-retest reliability between the two modalities, usability, user experience factors, and older adults' preference were determined. The results show perfect agreement between tablet and paper for the SARC-F and high agreement for the SF-36 physical scale and EQ-5D. Usability and user experience factors were perceived the same for both modalities. The majority of the participants preferred the tablet for health screening purposes, mainly because of its ease of use. This study shows that using tablets for health screenings among older adults does not affect test reliability, and that older adults prefer the tablet to paper for completing these tests.

Entities:  

Keywords:  Population health screening; tablet computers; test reliability

Mesh:

Year:  2018        PMID: 29678041

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  The use of technology in the context of frailty screening and management interventions: a study of stakeholders' perspectives.

Authors:  Holly Gwyther; Lex van Velsen; Rachel L Shaw; Barbara D'Avanzo; Maria Bujnowska-Fedak; Donata Kurpas; Katarzyna Szwamel; Jan-Willem Van't Klooster; Carol Holland
Journal:  BMC Med Inform Decis Mak       Date:  2019-06-11       Impact factor: 2.796

2.  Identification of community-dwelling older adults at risk of frailty using the PERSSILAA screening pathway: a methodological guide and results of a large-scale deployment in the Netherlands.

Authors:  Stephanie Jansen-Kosterink; Lex van Velsen; Sanne Frazer; Marit Dekker-van Weering; Rónán O'Caoimh; Miriam Vollenbroek-Hutten
Journal:  BMC Public Health       Date:  2019-05-03       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.